Shentracon Chemicals Limited Board Approves New Corporate Office in Mumbai
Shentracon Chemicals Limited announced board approval for establishing a new corporate office in Mumbai's Malad West area for enhanced operational efficiency and administrative convenience. The 30-minute board meeting on March 27, 2026, was presided over by Managing Director Amit Lalit Jain, with the company maintaining full SEBI regulatory compliance and ensuring no changes to its registered office in Kolkata.

*this image is generated using AI for illustrative purposes only.
Shentracon Chemicals Limited has announced the approval of a new corporate office in Mumbai, marking a strategic move to enhance operational efficiency and administrative convenience. The decision was made during a board meeting held on March 27, 2026, with the company maintaining full regulatory compliance under SEBI guidelines.
Board Meeting Outcome
The board of directors convened to consider and approve the establishment of the new corporate office facility. The meeting was conducted efficiently under the leadership of Managing Director Amit Lalit Jain.
| Meeting Details: | Information |
|---|---|
| Date: | March 27, 2026 |
| Start Time: | 04:00 P.M. |
| End Time: | 04:30 P.M. |
| Duration: | 30 minutes |
| Presiding Officer: | Amit Lalit Jain, Managing Director |
| DIN: | 05263766 |
New Corporate Office Specifications
The board approved the establishment of the new corporate office with specific location and operational parameters designed for better operational efficiency and administrative convenience.
| Parameter: | Details |
|---|---|
| Location: | Flat 1910, 19th Floor, 9 Business Bay |
| Property: | Khakhar Property |
| Address: | Behind Evershine Mall, Chincholi Bunder Malad (W) |
| City & PIN: | Mumbai 400064, Maharashtra |
| Primary Purpose: | Operational efficiency and administrative convenience |
Operational Changes
The new Mumbai office will serve as a significant operational hub for Shentracon Chemicals Limited. The company will maintain its books of accounts at this new corporate office, indicating the strategic importance of this facility in the company's administrative structure.
Importantly, the company has clarified that there is no change in the registered office, ensuring continuity in its legal and regulatory framework while expanding its operational capabilities.
Regulatory Compliance
The announcement was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company formally communicated this development to BSE Limited, maintaining transparency with stakeholders and regulatory authorities.
| Company Details: | Information |
|---|---|
| CIN: | L24299WB1993PLC059449 |
| Scrip Code: | 530757 |
| ISIN: | INE00US01011 |
| Registered Office: | 21, Ganesh Chandra Avenue, 5th Floor, Dharmatala, Kolkata |
The decision reflects Shentracon Chemicals Limited's strategic approach to operational expansion while maintaining full regulatory compliance and transparency with its stakeholders.
What specific operational synergies does Shentracon expect to achieve by relocating its books of accounts to Mumbai from Kolkata?
Will this Mumbai office expansion lead to increased headcount and what impact might this have on the company's operational costs?
How might this strategic move to Mumbai's business district affect Shentracon's ability to attract new clients or partnerships in the chemicals sector?




























